Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer

BACKGROUND: Bladder cancer (BLCA) is one of the most prevalent urinary system malignancies, with high mortality and recurrence. The present study aimed to identify potential tumor antigens for mRNA vaccines in BLCA and patient subtypes suitable for different immunotherapy. METHODS: Gene expression p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Zhang, Yanlong, Zhao, Li, Wang, Jiayu, Li, Jiaxing, Wang, Xi, Zhang, Min, Hu, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769457/
https://www.ncbi.nlm.nih.gov/pubmed/36569935
http://dx.doi.org/10.3389/fimmu.2022.1014638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769457/
https://www.ncbi.nlm.nih.gov/pubmed/36569935
http://dx.doi.org/10.3389/fimmu.2022.1014638

Ejemplares similares